| Selecting the risk cut off for the LLP model. |
Kevin ten Haaf |
Erasmus MC |
NLST |
Aug 27, 2017 |
NLST-343 |
| Selecting the risk cut off for the LLP model. |
Kevin ten Haaf |
Erasmus MC |
PLCO |
Sep 6, 2017 |
PLCO-301 |
| Selection of Eligible People for Lung Cancer Screening using Electronic Primary Care Data (SELECT) |
Aamir Khakwani |
University of Nottingham |
NLST |
Dec 5, 2019 |
NLST-611 |
| Self-Identified Race and Ethinicity: Ancestry and Geospatial Context |
Timothy Rebbeck |
Dana-Farber Cancer Institute, Inc. |
PLCO |
Aug 13, 2019 |
PLCO-501 |
| Self-reported dietary intake and serum metabolite correlations |
Kaitlyn Mazzilli |
National Cancer Institute |
PLCO |
Feb 13, 2019 |
PLCO-454 |
| Self-selection and decision to participate in clinical trials: evidence from screening trials |
Hualong Diao |
Stony Brook University |
NLST |
Nov 3, 2021 |
NLST-845 |
| Self-Supervised Multimodal Medical Image Analysis |
Cristian Simionescu |
Alexandru Ioan Cuza University |
NLST |
May 21, 2021 |
NLST-796 |
| Self-supervised multi-modal neural networks for predicting response to immunotherapy in lung cancer patients. |
Raquel Perez-Lopez |
Vall d'Hebron Institute of Oncology |
NLST |
Sep 6, 2022 |
NLST-950 |
| Self-supervised Training in chest X-rays domain. |
Song Luo |
Northwestern University |
PLCO |
Feb 16, 2022 |
PLCOI-920 |
| Semi or Unsupervised Human Activity Recognition Using Deep Learning |
Jiwon Lee |
University of Cincinnati |
IDATA |
Oct 18, 2024 |
IDATA-85 |
| Serial patterns of transvaginal ultrasound (TVU) and CA-125 levels and risk of ovarian cancer |
Clara Bodelon |
NCI, DCEG, HREB |
PLCO |
May 30, 2012 |
2012-0108 |
| Serum 25-hydroxyvitamin D, dietary vitamin D and non-Hodgkin Lymphoma: a Nested Case Control Study in the PLCO Trial |
Mark Purdue |
NCI, DCEG, OEEB |
PLCO |
Apr 21, 2006 |
2005-0021 |
| Serum concentrations of per- and polyfluoroalkyl substances and breast cancer risk among postmenopausal women: A nested case-control study in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Vicky Chang |
Occupational and Environmental Epidemiology Branch, DCEG, NCI |
PLCO |
Jul 9, 2021 |
2021-0016 |
| Serum Creatinine and Prostate Cancer Risk in the PLCO Study |
Stephanie Weinstein |
DCEG - NEB |
PLCO |
Dec 15, 2009 |
2009-0555 |
| Serum Estrogens and Subsequent Risk of Prostate Cancer |
Amanda Black |
NCI, DCEG, EBP |
PLCO |
Jan 28, 2010 |
2009-0562 |
| Serum IgE and Risk of Pancreatic Cancer |
Sara Olson |
Memorial Sloan-Kettering Cancer Center |
PLCO |
Jan 21, 2010 |
2009-0563 |
| Serum inflammation markers and esophageal adenocarcinoma risk |
Michael Cook |
DCEG - Other |
PLCO |
Mar 9, 2015 |
2015-0056 |
| Serum Levels of Autoantibodies and the Risk of Non-Hodgkin Lymphoma and Multiple Myeloma |
Jonathan Hofmann |
DCEG - Other |
PLCO |
Mar 9, 2015 |
2015-0051 |
| Serum Levels of Cytokines, Other Immunologic Markers and non-Hodgkin Lymphoma: A Nested Case-Control Study in the PLCO Trial |
Mark Purdue |
NCI, DCEG, OEEB |
PLCO |
Apr 21, 2006 |
2005-0015 |
| Serum levels of per- and polyfluorinated substances and risks of non-Hodgkin lymphoma and thyroid cancer |
Mark Purdue |
DCEG, NCI |
PLCO |
Sep 18, 2020 |
2020-0003 |
